Search research articles
Contact Us
Filters
Showing results (1-10 of 115) with videos related to
Page
of 12
Sort By:
Neurourology and Urodynamics
|
October 8, 2010
Intermittent catheterization with hydrophilic catheters as a treatment of chronic neurogenic urinary retention
Emmanuel Chartier-Kastler, Pierre Denys
La Revue Du Praticien
|
November 2, 2011
[Conservative treatment of female urinary incontinence]
Jacques Kerdraon, Pierre Denys, Gérard Amarenco
Toxins
|
May 24, 2019
Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport<sup>®</sup>) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile Dysfunction-Case Studies
Francois Giuliano, Charles Joussain, Pierre Denys
Toxins
|
April 21, 2022
Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin<sup>®</sup>) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series
Francois Giuliano, Pierre Denys, Charles Joussain
The Journal of Sexual Medicine
|
December 23, 2021
Long Term Effectiveness and Safety of Intracavernosal Botulinum Toxin A as an Add-on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 Injections for Erectile Dysfunction
Francois Giuliano, Charles Joussain, Pierre Denys
Annals of Physical and Rehabilitation Medicine
|
June 18, 2017
What do we know about neurogenic bladder prevalence and management in developing countries and emerging regions of the world?
Mikolaj Przydacz, Pierre Denys, Jacques Corcos
Toxins
|
June 27, 2023
Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data
François Giuliano, Pierre Denys, Charles Joussain
Autonomic Neuroscience : Basic & Clinical
|
July 10, 2026
Treating neurogenic detrusor overactivity in order to manage autonomic dysreflexia - A systematic review
Ba Thien Le, Pierre Denys, Charles Joussain
Toxins
|
October 25, 2024
Real-World Use of Intradetrusor Botulinum Toxin Injections: A Population-Based Study from France
Alain Ruffion, Pierre Karam, Anne Forestier, et al.
Current Opinion in Urology
|
November 25, 2010
Botulinum neurotoxin A for male lower urinary tract symptoms
Emmanuel Chartier-Kastler, Ulrich Mehnert, Pierre Denys, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 115) with videos related to
Sort By:
Page
of 12
Neurourology and Urodynamics
|
October 8, 2010
Intermittent catheterization with hydrophilic catheters as a treatment of chronic neurogenic urinary retention
Emmanuel Chartier-Kastler, Pierre Denys
La Revue Du Praticien
|
November 2, 2011
[Conservative treatment of female urinary incontinence]
Jacques Kerdraon, Pierre Denys, Gérard Amarenco
Toxins
|
May 24, 2019
Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport<sup>®</sup>) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile Dysfunction-Case Studies
Francois Giuliano, Charles Joussain, Pierre Denys
Toxins
|
April 21, 2022
Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin<sup>®</sup>) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series
Francois Giuliano, Pierre Denys, Charles Joussain
The Journal of Sexual Medicine
|
December 23, 2021
Long Term Effectiveness and Safety of Intracavernosal Botulinum Toxin A as an Add-on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 Injections for Erectile Dysfunction
Francois Giuliano, Charles Joussain, Pierre Denys
Annals of Physical and Rehabilitation Medicine
|
June 18, 2017
What do we know about neurogenic bladder prevalence and management in developing countries and emerging regions of the world?
Mikolaj Przydacz, Pierre Denys, Jacques Corcos
Toxins
|
June 27, 2023
Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data
François Giuliano, Pierre Denys, Charles Joussain
Autonomic Neuroscience : Basic & Clinical
|
July 10, 2026
Treating neurogenic detrusor overactivity in order to manage autonomic dysreflexia - A systematic review
Ba Thien Le, Pierre Denys, Charles Joussain
Toxins
|
October 25, 2024
Real-World Use of Intradetrusor Botulinum Toxin Injections: A Population-Based Study from France
Alain Ruffion, Pierre Karam, Anne Forestier, et al.
Current Opinion in Urology
|
November 25, 2010
Botulinum neurotoxin A for male lower urinary tract symptoms
Emmanuel Chartier-Kastler, Ulrich Mehnert, Pierre Denys, et al.
Page
of 12